Mani, Inc. (7730.T) Stock
Mani, Inc.

Company profile
Mani reported revenue of 29.97 billion JPY for fiscal year 2025, up 5.1% from fiscal year 2024, and net income of 4.64 billion JPY. That is a net profit margin of 15.5% for fiscal year 2025. Its largest business segment, Eyeless Needle Products, brought in 37% of segment revenue in fiscal year 2025; China was the largest region with 25%. Our analysis of its filings shows revenue growing from 24.49 billion JPY in fiscal year 2023 to 29.97 billion JPY in fiscal year 2025, 10.6% a year on average.
What stands out
- Revenue in fiscal year 2025 was the highest of the last 5 fiscal years.
Figures from company filings; latest fiscal year ended August 31, 2025.
About Mani, Inc.
Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, and stainless wire needles; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also provides surgical eyeless, eyed, taper point, cutting, ophthalmic needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. Mani, Inc. was founded in 1956 and is headquartered in Utsunomiya, Japan.
Largest shareholders
- Matsutani Kanji Family9.906 %9.91%
- Mani, Inc.7.94%
- Matsutani Family4.751 %4.75%
- Masamitsu Matsutani3.815 %3.81%
- Mani Matsutani Medical Scholarship Foundation2.99%
Share of the company, as of September 25, 2026
Leadership
- Masaya Watanabe — CEO, President, Representative Executive Officer & Director, 67
- Masahiko Saito — Chairperson of Board of Executive Officers & GM of Technical Fellow, 58
- Takayuki Yamamoto — Managing Executive Officer, Chief Risk Management Officer, Head of Corporate Planning Office & CFO, 60
- Kentaro Inatomi — Administrative Officer & Department Head of Global Operations Dept., 57
- Shuichi Kurita — Sr Mng Exec. Offcr, Hd of Bus Div, Ofc & Head of Human Resources Dept., 64
How much revenue does Mani make?
Mani reported 29.97 billion JPY in revenue for fiscal year 2025, up 5.1% from 28.51 billion JPY in fiscal year 2024.
What is Mani's largest business segment?
Eyeless Needle Products, with 11.18 billion JPY or 37% of segment revenue in fiscal year 2025. Next: Dental Products (32%) and Surgical Products (31%).
Where does Mani make most of its revenue?
China: 25% of revenue by region in fiscal year 2025, followed by Asia (20%).
What companies are similar to Mani?
Listed companies of a similar size in the same industry (various healthcare equipment manufacturing) include Olympus Corporation (7733.T), Fukuda Denshi Co., Ltd. (6960.T), Nipro Corporation (8086.T), Medikit Co.,Ltd. (7749.T).
How has Mani's revenue changed over the last 5 fiscal years?
Revenue by fiscal year: FY2021, 17.19 billion JPY; FY2022, 20.42 billion JPY; FY2023, 24.49 billion JPY; FY2024, 28.51 billion JPY; FY2025, 29.97 billion JPY.
Company Information
Contact & Links
Data as of .
How to cite: DataPorium, “Mani, Inc. (7730.T)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/7730.T